Ratings Aegon Ltd. Borsa Italiana

Equities

1AGN

BMG0112X1056

Real-time Estimate Tradegate 08:16:44 2024-04-29 am EDT 5-day change 1st Jan Change
5.892 EUR +27.49% Intraday chart for Aegon Ltd. 0.00% 0.00%

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Its low valuation, with P/E ratio at 8.42 and 6.7 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • This company will be of major interest to investors in search of a high dividend stock.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Life & Health Insurance

1st Jan change Capi. Investor Rating ESG Refinitiv
0.00% 10.89B -
+16.17% 79.51B
B-
+6.49% 50.22B
B+
+1.35% 48.11B
B
+9.53% 42.2B
B+
+6.55% 39.71B
B+
+20.13% 37.78B
B
+2.84% 30.07B
B
-7.77% 27.56B
B-
-16.21% 24.71B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes